Compared to HFS protocol (100 Hz, 1s stimulation) TBS may be closer to some physiological conditions (Latif-Hernandez et al., 2020)
Multiple peer-reviewed studies confirm dose-dependent increases in circulating growth hormone, with peak effects typically observed 3060 minutes post-injection
Impairment of mitochondrial function and structure is closely associated with HF, while disruption of glucolipid metabolism and mitochondrial damage can influence each other 37
But when it comes to people who are overweight, as opposed to those with obesity, the benefits of weight loss are less certain
Status Not FDA-approved for human use
After tele health consultation medication is delivered in 3-5 business days by UPS 3months GLP-1/GIP Program Care Clinics 3 months GLP-1/GIP weight loss plan includes progressively increasing doses of Tirzepatide from 2.5 mg for 3 weeks to 5 mg for 4 weeks and ending at 7.5 mg for last 5 weeks